Our news

  • The Cochrane Airways Priority Setting Group (CAPSG), formed of stakeholders including patients and carers, in conjunction with the Editorial Board, have prioritised some topics for new Cochrane Reviews. These are available here, together with details of how to apply to write a review (which requires completion of a review proposal form). For a...
    November 11 2020
  • What is myofunctional therapy?Myofunctional therapy teaches people to do daily exercises to strengthen their tongue and throat muscles. Myofunctional therapy may reduce the intensity of the OSA symptoms and reduce daytime sleepiness on its own, or combined with CPAP. Therapy can include exercises involving several muscles and areas of the mouth,...
    November 9 2020
  • Cochrane authors based at Cochrane Airways in St George’s University of London and the Cochrane CET have updated a review on Sublingual immunotherapy for asthma. Adding 14 new studies to give a total of 66 studies, they bring the review up-to-date. Unfortunately, even though there were a large number of people involved in the trial -  nearly...
    September 15 2020
  • Researchers from Japan have completed a Cochrane review which explores whether proton pump inhibitors (PPIs) are effective in (a) reducing chronic obstructive pulmonary disease (COPD) exacerbations, and (b) improving quality of life for people with COPD.The team found only one study, with 103 participants. This study showed that giving PPIs to...
    August 25 2020
  • This overview of Cochrane Review of interventions for escalation of therapy for acute exacerbations of asthma in children provides the most up-to-date information to people making decisions about healthcare.For children with acute severe asthma requiring additional treatment, the review found that:Intravenous magnesium sulfate (a bronchodilator...
    August 5 2020
  • Today we launch a report on our 'whole-of-scope' priority-setting work. One hundred uncertainties submitted by the public were ranked by a group of stakeholders - the Cochrane AIrways Priority-setting group (CAPSG). The top uncertainties were interventions to prevent asthma deaths, evidence mapping exercise for COPD, and interventions to help...
    May 6 2020
  • Clinical trials are used to determine whether an intervention (treatment) is safe and effective compared to another intervention. Safety and efficacy are evaluated by measuring a range of outcomes (such as measures of quality of life, admission to hospital, or lung function). Clinical trials evaluating interventions for the management of chronic...
    May 5 2020
  • Phillippa Poole from the University of Auckland and colleagues from Cochrane Airways editorial team at St George’s University of London have updated the Cochrane Review: Phosphodiesterase-4 inhibitors for Chronic obstructive pulmonary disease (COPD).The team added a total of five new studies from the search run in March 2020. The studies...
    May 4 2020
  • We have gathered together a selection of links to information and resources related to COVID-19 from the respiratory and evidence syntheses communities, including guidelines, rapid reviews and 'living' evidence syntheses, primary study registers and search strategy resources.Respiratory societiesATS COVID-19 Resource Center (American Thoracic...
    April 7 2020
  • Dear colleagues We recognise that these are uncertain times and the impact of the COVID-19 pandemic will be felt by many of you. We want to reassure you that your health, and your current priorities at work and home, are of the utmost importance to us. For those of you with any ongoing or pending tasks relating to a Cochrane Airways Review or...
    April 1 2020

Pages

Subscribe to Our news